Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 2104-2110

  Lee, Tim C ^a   Miller, Walter L ^a,b   Auchus, Richard J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MEDROXYPROGESTERONE ACETATE;

ARTICLE; DRUG EFFECT; DRUG MECHANISM; HORMONE DEFICIENCY; HUMAN; HUMAN CELL; HYPERANDROGENISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; PRIORITY JOURNAL; STEROIDOGENESIS;

RODENTIA;

EID: 0033304948     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.6.2104     Document Type: Article

References (45)

1. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation ('familial testotoxicosis'): Effects of a potent leutenizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases
2. Sexual precocity associated with functional follicular cysts, prepubertal gonadotropins, and LRF response and fluctuating estrogen levels
3. Pathogenesis of sexual precocity
4. High dose vs. low dose medroxyprogesterone acetate: A randomized trial in advanced breast cancer
5. Predictive value of serum medroxyprogesterone acetate concentration for response in advanced or recurrent breast cancer
6. Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients
7. Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients
8. Prenatal treatment of congenital adrenal hyperplasia - A promising experimental therapy of unproven safety
9. Tissue-specific, cAMP-induced, and phorbol ester repressed expression from the human P450c17 promoter in mouse cells
10. Direct effects of medroxyprogesterone acetate (MPA) and magestrol acetate (MGA) on rat testicular steroidogenesis
11. 5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer
12. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
13. The multiple murine 3β-hydroxysteroid dehydrogenase isoforms: Structure, function, and tissue- and developmentally specific expression
14. Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene
15. Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency
16. In vitro metabolism of dexamethasone (DEX) in human liver and kidney: The involvement of CYP3A4 and CYP17 (17,20-lyase) and molecular modeling studies
17. 4-isomerase in human adrenals and gonads
18. Yeast expression of animal and plant P450s in optimized redox environments
19. Improved method for high efficiency transformation of intact yeast cells
20. Serine phosphorylation of human P450c17 increases 17,20 lyase activity: Implications for adrenarche and for the polycystic ovary syndrome
21. 106 and P450 reductase
22. Preparation of 14,15 secoestra-1,3,5(10)-trien-15-ynes, inhibitors of estradiol dehydrogenase
23. The regulation of 17,20 lyase activity
24. The regulation of human P450c17 activity: Relationship to premature adrenarche and the polycystic ovary syndrome
25. Dexamethasone suppression tests: Usefulness of simultaneous measurement of plasma cortisol and dexamethasone
26. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome P450scc and 3β-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells
27. Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast
28. Regulation of proteins of the cholesterol side-chain cleavage system in Y-1 and JEG-3 cells
29. Human steroidogenic acute regulatory protein (StAR): Functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and an expressed pseudogene to chromosome 13
30. Congenital lipoid adrenal hyperplasia: The human gene knockout of the steroidogenic acute regulatory protein
31. Cloning and sequence of the human gene encoding P450c17 (steroid 17α-hydroxylase/17,20 lyase): Similarity to the gene for P450c21
32. Cytochrome P450c17 (steroid 17α-hydroxylase/17,20 lyase): Cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues
33. Developmental expression of genes for the steroidogenic enzymes P450scc (20,22 desmolase), P450c17 (17α-hydroxylase/17,20 lyase) and P450c21 (21-hydroxylase) in the human fetus
34. 5
35. Aroomatase inihibitors in advanced breast cancer: Mechanism of action and clinical implications
36. Endocrine therapy of prostate cancer: Optimal form and timing
37. Treatment of post-orchiectomy gynecomastia with testolactone
38. A prelimmary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia
39. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
40. Endometriosis: Medical therapy
41. Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase
42. Human placental 3β-hydroxy-5-ene-steroid dehydrogenase and steroid 5→4-ene-isomerase: Purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes
43. Neurosteroids: Biochemistry, modes of action, and clinical relevance
44. 5 in the biosynthesis of androgens by human P450c17
45. Modulation of the activity of human 17α-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: Endocrinological and mechanistic implications